Portola Pharma (PTLA) Stock Price, Quote, News and Overview
NASDAQ:PTLA - Nasdaq -
PTLA Quote, Performance and Key Statistics
18.03
+0.04 (+0.22%)
The current stock price of PTLA is 18.03 null. In the past month the price increased by 0.56%. In the past year, price decreased by -31.65%.
About PTLA
Company Profile
Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.
Company Info
Portola Pharma
270 EAST GRAND AVENUE
SOUTH SAN FRANCISCO CA 94080
CEO: Scott Garland
Phone: 650-246-7000
Portola Pharma / PTLA FAQ
What is the stock price of Portola Pharma today?
The current stock price of PTLA is 18.03 null. The price increased by 0.22% in the last trading session.
What is the ticker symbol for Portola Pharma stock?
The exchange symbol of Portola Pharma is PTLA and it is listed on the Nasdaq exchange.
On which exchange is PTLA stock listed?
PTLA stock is listed on the Nasdaq exchange.
What is Portola Pharma worth?
Portola Pharma (PTLA) has a market capitalization of 1.42B null. This makes PTLA a Small Cap stock.
What are the support and resistance levels for Portola Pharma (PTLA) stock?
Portola Pharma (PTLA) has a support level at 17.97 and a resistance level at 18.04. Check the full technical report for a detailed analysis of PTLA support and resistance levels.
Should I buy Portola Pharma (PTLA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PTLA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PTLA, evaluating the profitability, health, valuation and growth aspects
- Portola Pharma (PTLA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Portola Pharma (PTLA) Sales and EPS estimates to see what analysts future expectations are.
- Portola Pharma (PTLA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Portola Pharma (PTLA) Insider and Institutional Ownership to learn about the owners and their transactions.
- Portola Pharma (PTLA) Stock Chart to make your own analysis
- Portola Pharma (PTLA) Latest news and press-releases to stay up to date.
Does Portola Pharma (PTLA) stock pay dividends?
PTLA does not pay a dividend.
What is the Price/Earnings (PE) ratio of Portola Pharma (PTLA)?
Portola Pharma (PTLA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.72).
PTLA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to PTLA. When comparing the yearly performance of all stocks, PTLA is one of the better performing stocks in the market, outperforming 94.88% of all stocks.
PTLA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PTLA. PTLA has a bad profitability rating. Also its financial health evaluation is rather negative.
PTLA Financial Highlights
Over the last trailing twelve months PTLA reported a non-GAAP Earnings per Share(EPS) of -3.72. The EPS increased by 21.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -232.73% | ||
| ROA | -54.8% | ||
| ROE | N/A | ||
| Debt/Equity | 4.77 |
PTLA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 88% to PTLA. The Buy consensus is the average rating of analysts ratings from 5 analysts.